RXRX vs BBAI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

RXRX

42.2
AI Score
VS
BBAI Wins

BBAI

65.0
AI Score

Investment Advisor Scores

RXRX

42score
Recommendation
HOLD

BBAI

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RXRX BBAI Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -60.1% 13.2% BBAI
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 42.2/100 65.0/100 BBAI
Profit Margin 0.0% -65.2% RXRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

RXRX 1M: +22.3% · 3M: +4.4% BBAI 1M: -11.2% · 3M: -26.8%

Current Technical Phase

RXRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 62

RSI (14): 62.2 · Price: $4.14

BBAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.7%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $2.62

Fundamentals Snapshot

Metric RXRX BBAI
Market Cap — —
Forward P/E -4.5 -17.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 0.1%
Gross Margin -7.2% 0.3%
Operating Margin -17.6% -0.7%
EPS -1.02 -0.02
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BBAI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.